References

1. de Vries, E.; Bray, F.I.; Coebergh, J.W.; Parkin, D.M. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: Rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int. J. Cancer 2003, 107, 119-126.

2. Australian Institute of Health and Welfare (AIHW); Australian Association of Cancer Registries (AICR). Cancer in Australia 1996: Incidence and mortality data for 1996 and selected data for 1997 and 1998; AIHW (Cancer Series): Canberra, Australia, 1999.

3. Norris, W. A case of fungoid disease. Edinb. Med. Surg. J. 1820, 16, 562-565.

4. Ford, D.; Bliss, J.M.; Swerdlow, A.J.; Armstrong, B.K.; Franceschi, S.; Green, A.; Holly, E.A.; Mack, T.; MacKie, R.M.; Osterlind, A.; Walter, S.D.; Peto, J.; Easton, D.F.; for The International Melanoma Analysis Group (IMAGE) Risk of cutaneous melanoma associated with a family history of the disease. Int. J. Cancer 1995, 62, 377 - 381.

5. Aitken, J.F.; Duffy, D.L.; Green, A.; Youl, P.; MacLennan, R.; Martin, N.G. Heterogeneity of melanoma risk in families of melanoma patients. Am. J. Epidemiol. 1994, 140, 961-973.

6. Aitken, J.F.; Bailey-Wilson, J.; Green, A.C.; MacLennan, R.; Martin, N.G. Segregation analysis of cutaneous melanoma in Queensland. Genet. Epidemiol. 1998, 15, 391-401.

7. Hayward, N.K. Genetics of melanoma predisposition. Oncogene 2003, 22, 3053-3062.

8. Palmer, J.S.; Duffy, D.L.; Box, N.F.; Aitken, J.F.; O'Gorman, L.E.; Green, A.C.; Hayward, N.K.; Martin, N.G.; Sturm, R.A. Melanocortin-1 receptor polymorphisms and risk of melanoma: Is the association explained solely by pigmentation phenotype? Am. J. Hum. Genet. 2000, 66, 176-186.

9. Box, N.F.; Duffy, D.L.; Chen, W.; Stark, M.; Martin, N.G.; Sturm, R.A.; Hayward, N.K. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am. J. Hum. Genet. 2001, 69, 765-773.

10. van der Velden, P.A.; Sandkuijl, L.A.; Bergman, W.; Pavel, S.; van Mourik, L.; Frants, R.R.; Gruis, N.A. Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am. J. Hum. Genet. 2001, 69, 774-779.

11. Goldstein, A.M.; Fraser, M.C.; Struewing, J.P.; Hussussian, C.J.; Ranade, K.; Zametkin, D.P.; Fontaine, L.S.; Organic, S.M.; Dracopoli, N.C.; Clark, W.H., Jr.; Tucker, M.A. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N. Engl. J. Med. 1995, 333, 970-974.

Kannengiesser, C.; Avril, M.F.; Spatz, A.; Laud, K.; Lenoir, G.M.; Bressac-de-Paillerets, B. CDKN2A as a uveal and cutaneous melanoma susceptibility gene. Genes Chromosomes Cancer 2003, 38, 265-268. Cannon-Albright, L.A.; Goldgar, D.E.; Meyer, L.J.; Lewis, C.M.; Anderson, D.E.; Fountain, J.W.; Hegi, M.E.; Wiseman, R.W.; Petty, E.M.; Bale, A.E.; Olopade, O.; Diaz, M.; Kwiatkowski, D.; Piepkorn, M.; Zone, J.; Skolnick, M. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 1992, 258, 1148-1152.

14. Liu, L.; Dilworth, D.; Gao, L.; Monzon, J.; Summers, A.; Lassam, N.; Hogg, D. Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma. Nat. Genet. 1999, 21, 128-132.

15. Harland, M.; Mistry, S.; Bishop, D.T.; Bishop, J.A. A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees. Hum. Mol. Genet. 2001, 10, 2679-2786.

16. Loo, J.C.; Liu, L.; Hao, A.; Gao, L.; Agatep, R.; Shennan,

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment